BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15950923)

  • 1. Thermal inactivation of the reductase domain of cytochrome P450 BM3.
    Jamakhandi AP; Jeffus BC; Dass VR; Miller GP
    Arch Biochem Biophys; 2005 Jul; 439(2):165-74. PubMed ID: 15950923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
    Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
    FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
    Sevrioukova I; Truan G; Peterson JA
    Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical residues involved in FMN binding and catalytic activity in cytochrome P450BM-3.
    Klein ML; Fulco AJ
    J Biol Chem; 1993 Apr; 268(10):7553-61. PubMed ID: 8463285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the structural stability of the multidomain enzyme flavocytochrome P-450 BM3.
    Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
    Biochim Biophys Acta; 1996 Sep; 1296(2):127-37. PubMed ID: 8814218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P450 BM3: the very model of a modern flavocytochrome.
    Munro AW; Leys DG; McLean KJ; Marshall KR; Ost TW; Daff S; Miles CS; Chapman SK; Lysek DA; Moser CC; Page CC; Dutton PL
    Trends Biochem Sci; 2002 May; 27(5):250-7. PubMed ID: 12076537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
    Haines DC; Sevrioukova IF; Peterson JA
    Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of electron transfer in the complex of cytochrome P450 3A4 with the flavin domain of cytochrome P450BM-3 as evidence of functional heterogeneity of the heme protein.
    Fernando H; Halpert JR; Davydov DR
    Arch Biochem Biophys; 2008 Mar; 471(1):20-31. PubMed ID: 18086551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of electron transfer in neuronal NO synthase.
    Daff S; Noble MA; Craig DH; Rivers SL; Chapman SK; Munro AW; Fujiwara S; Rozhkova E; Sagami I; Shimizu T
    Biochem Soc Trans; 2001 May; 29(Pt 2):147-52. PubMed ID: 11356143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytically functional flavocytochrome chimeras of P450 BM3 and nitric oxide synthase.
    Fuziwara S; Sagami I; Rozhkova E; Craig D; Noble MA; Munro AW; Chapman SK; Shimizu T
    J Inorg Biochem; 2002 Sep; 91(4):515-26. PubMed ID: 12237219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
    Hodgson AV; Strobel HW
    Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
    Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
    Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of flavin reoxidation in P450 BM3 by diphenyliodonium chloride.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1996 Feb; 24(1):17S. PubMed ID: 8674653
    [No Abstract]   [Full Text] [Related]  

  • 20. Redox control of the catalytic cycle of flavocytochrome P-450 BM3.
    Daff SN; Chapman SK; Turner KL; Holt RA; Govindaraj S; Poulos TL; Munro AW
    Biochemistry; 1997 Nov; 36(45):13816-23. PubMed ID: 9374858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.